咳露口服液与氨溴索雾化吸入用于慢阻肺急性加重期患者治疗中的临床效果

任军峰

（陕西省兴平市秦岭医院，陕西 咸阳，713100）

浏览次数：243次 下载次数：309次

摘要：

目的 分析咳露口服液与氨溴索雾化吸入治疗慢阻肺急性加重期患者的临床效果。方法 选取我院2015年4月至2016年9月收治的94例慢阻肺急性加重期患者，采用随机数字表法将其分为参照组与研究组，各47例。参照组患者进行平喘、 吸氧、祛痰、抗感染等常规治疗，研究组患者在参照组治疗基础上再给予咳露口服液与氨溴索雾化吸入治疗，对两组患者的临床效果进行观察。结果 参照组患者的临床治疗总有效率为65.96%，研究组患者的临床治疗总有效率为93.62%，研究组患者的临床治疗总有效率明显高于参照组（P<0.05）。结论 慢阻肺急性加重期患者在常规治疗的基础上联合应用咳露口服液与 氨溴索雾化吸入治疗，可以大大提高临床疗效，使患者的病情得到有效地改善，加快患者病情的恢复，促进患者的呼吸道功能的恢复，值得在临床中应用与推广。

关键词：慢阻肺急性加重期；咳露口服液；氨溴索雾化吸入

中图分类号：R563.9文献标志码：A文章编号：2096-1413(2017)17-0047-02

Clinical effect of cough syrup oral liquid combined with ambroxol aerosol inhalation in the treatment of AECOPD
REN Jun-feng
(Qinling Hospital of Xingping, Xianyang 713100, China)

ABSTRACT: Objective To analyze the clinical effect of cough syrup oral liquid combined with ambroxol aerosol inhalation in the treatment of acute exacerbation chronic obstructive pulmonary disease (AECOPD). Methods Ninety-four cases of AECOPD patients admitted in our hospital from April 2015 to September 2016 were selected, and divided into control group and study group according to the method of random number, with 47 cases in each group. The control group received conventional treatment therapys, such as asthma, oxygen, expectorant and anti infection; while the study group accepted cough syrup oral liquid with ambroxol inhalation therapy on the basis of the control group. The clinical effects of the two groups were compared. Results The total effective rate of the study group was 93.62%, which was significantly higher than 65.96% of the control group (P<0.05). Conclusion For patients with AECOPD, cough syrup oral liquid and ammonia bromine cable atomization inhalation on the basis of routine therapy can greatly enhance the patients` clinical curative effect, improve the patients` syndrome, speed up the patients` recovery and respiratory function, which is worthy of promotion in clinic.
KEYWORDS: AECOPD; cough syrup oral liquid; ammonia bromine cable atomization inhalation

参考文献：
[1] 王应强,杨宗霞,李幼平,等.我国示范乡镇卫生院基本药物循证评价与遴选之七:慢性阻塞性肺疾病[J].中国循证医学杂志,2012,12(8):907-922.
[2] 陈英,冯淬灵,李根茂,等.清金化痰汤对COPD模型大鼠肺组织中性粒细胞弹性蛋白酶及黏蛋白5AC 表达的影响[J].吉林中医药,2016,36(1):65-71.
[3] 彭顺刚,卢建刚,曾秋蓉,等.肠内营养支持对老年慢阻肺急性加重期合并呼吸衰竭患者心肺功能及免疫功能的影响[J].临床肺科杂志,2016,21(2):261-264.
[4] 谭经福,叶永青,杨龙峰,等.噻托溴铵粉联合布地奈德福莫特罗吸入治疗支气管哮喘-慢性阻塞性肺疾病重叠综合征的短期疗效[J]. 临床荟萃,2016,31(8):886-888,892.
[5] 王仁,曾健,王臻,等.持续双水平气道正压通气和间断双水平气道正压通气治疗慢性阻塞性肺疾病急性加重期的临床效果观察[J].临床肺科杂志,2016,21(9):1646-1649.
[6] 张明,彭夏莹,刘守智,等.慢性阻塞性肺疾病急性加重患者肺动脉与主动脉直径比>1 和血浆尿钠肽、C反应蛋白、白细胞介素6的相关性分析[J].中国呼吸与危重监护杂志,2015,9(3):255-259.
[7] 潘华琴,姜克家,秦少云,等.慢性阻塞性肺疾病外周血CD3+、CD4+、 CD8+细胞表达变化及其与肺功能损伤的相关性[J].甘肃医药,2015,34(9):682-684.